Atrophic Gastritis Clinical Trial
Official title:
Grading Atrophic Gastritis by a New Quantitative Method Using Confocal Laser Endomicroscopy Probe (p-CLE): First Results of a Prospective Cohort Study
Atrophic gastritis (AG) is a chronic disease, associated to gastric adenocarcinoma moreover if severity AG is present. Sydney system classified AG as mild, moderate and severe, but with moderate interobserver agreement, due to this system is based in a visual analogic scale (qualitative analysis). Confocal endomicroscopy showed an accuracy of 98% for diagnosis gastric diseases, but when grading AG still remains a qualitative measure. Recently, a new software called "Cellvizio® Viewer" (CV) permits to measure in micrometers (µm) the structures observed after confocal laser endomicroscopy probe studies. Based on the hypothesis that AG severity is correlated with crypts size diminution, the aim of this study is to determine a quantitative way to classify the severity of AG measuring the crypt area and inter-crypt spaces in patients with AG.
Consecutive patients that underwent to upper endoscopy (UE) evaluation were included in this
study. All subjects went to UE according to standard procedure, under propofol sedation, and
using a high definition endoscope with a working channel of 2.8 mm After gastric mucosa
inspection using endoscopy, in vivo microscopy analysis at x1000 magnification was done
using confocal laser endomicroscopy probe (p-CLE) in all patients.
During UE 5 biopsy sites were performed in accordance to update Sydney system first using
p-CLE and them by biopsy forceps from the same site (2 from the lesser and greater curvature
of the antrum about 2-3 cm near the pylorus, 2 from the middle portion of the lesser and
greater curvatures of the corpus about 8 cm from the cardia, and 1 from the angulus). p-CLE
images were recorded as video frames and pictures during in vivo microscopy analysis.
For histopathology all specimens were fixed in 10% formalin. An experienced histopathologist
analyzed the histological features of each sample with hematoxylin and eosin staining and
made the diagnosis according to the updated Sydney classification.
At p-CLE normal crypt was defined by using the classification of Wang et al. After
histopathology confirm GA, crypts were analyzed using the CV software that is a
post-procedure tool that could be installed in computers, working as a laboratory data
analyzer. This software permits to measure diameters of the microscopy findings in an
escalade model in micrometers, using different colors lines and giving their results in a
table that could be exported as excel table for analysis of the results The crypts diameters
were measuring to determine the area by using the elliptic area formula (A = π.d1.d2). The
inter-crypt space was also measured and defined as the mean of each measured distance
between the studied crypt and it's adjacent.
The cutoff value between mild, moderate and severe GA, crypts area was classified across
tertiles, expressing its distribution using a box-spot graphic. For relationship between
crypt area (CA) and inter-crypt space, quadratic polynomial regression was used. Data was
processed using IBM® SPSS® Statistics.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02724280 -
Linked Color Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
|
N/A | |
Completed |
NCT02597517 -
New Technology to Differentiate Normal Gastric Mucosa From Helicobacter Pylori Associated Gastritis and Gastric Atrophy
|
N/A | |
Recruiting |
NCT05209633 -
Efficacy and Safety of Using Granules Dendrobii for the Treatment of Chronic Atrophic Gastritis
|
Phase 2 | |
Recruiting |
NCT04022109 -
Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach
|
||
Recruiting |
NCT05053945 -
Helicobacter Pylori, Atrophic Gastritis and Intestinal Metaplasia Registry and Prospective Study
|
||
Recruiting |
NCT02047994 -
Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
|
Phase 4 | |
Completed |
NCT01896310 -
New Classification of Stomach Using Probe-based Confocal Laser Endomicroscopy
|
N/A | |
Recruiting |
NCT05916014 -
AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis
|
||
Completed |
NCT05969444 -
Endoscopic Surveillance on a High-risk Population for Gastric Cancer in Latin America: The ECHOS Cohort Study.
|
||
Recruiting |
NCT04191551 -
The GAstric Precancerous Conditions Study
|
||
Enrolling by invitation |
NCT03228095 -
Volatiles in Breath and Headspace Analysis - Diagnostic Markers
|
||
Recruiting |
NCT02833363 -
Difference of Gastric Microbiota in the Process of Correa's Model.
|
Phase 4 | |
Enrolling by invitation |
NCT05021029 -
A Study of Pre-Malignant Gastric Conditions
|
||
Recruiting |
NCT04085211 -
Image-Enhanced Endoscopy in the Gastrointestinal Tract
|
||
Completed |
NCT02332213 -
Volatile Markers in Digestive Cancer
|
||
Recruiting |
NCT04613570 -
SUrveillance of PREMalignant Stomach - Individualized Endoscopic Follow-up
|
N/A | |
Recruiting |
NCT06203327 -
Atrophic Gastritis Predicts the Risk of Gastric Cancer
|
||
Active, not recruiting |
NCT05631015 -
Artificial Intelligence for Determination of Gastroscopy Surveillance Intervals
|
||
Not yet recruiting |
NCT04251403 -
Novel Approach to Surveillance of Gastric Lesions
|
Early Phase 1 | |
Completed |
NCT03380052 -
OLGA and OLGIM Stage System for Gastric Cancer
|